Rheumatoid arthritis: involvement of the synovium in the preclinical phase?

Background and objectives The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease, is poorly understood. Increased serum levels of acute phase reactants and autoantibodies (IgM rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA)) may be det...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2011-03, Vol.70 (Suppl 2), p.A5-A6
Hauptverfasser: de Hair, M J, van de Sande, M G, Bos, W, van der Leij, C, Smith, M D, Maas, M, van Schaardenburg, D, Dijkmans, B A, Gerlag, D M, Tak, P P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A6
container_issue Suppl 2
container_start_page A5
container_title Annals of the rheumatic diseases
container_volume 70
creator de Hair, M J
van de Sande, M G
Bos, W
van der Leij, C
Smith, M D
Maas, M
van Schaardenburg, D
Dijkmans, B A
Gerlag, D M
Tak, P P
description Background and objectives The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease, is poorly understood. Increased serum levels of acute phase reactants and autoantibodies (IgM rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA)) may be detected several years before the development of clinical signs and symptoms. Moreover, animal models of RA as well as examination of clinically uninvolved joints from established RA patients have suggested that clinically manifest arthritis may be preceded by an asymptomatic phase characterised by synovial inflammation. However, it is unknown whether the disease process starts in the synovium or at other sites in the body. Materials and methods Fifty five individuals without any evidence of arthritis upon physical examination who were positive for IgM-RF and/or ACPA were included in the study and prospectively followed to assess arthritis development. To evaluate synovial inflammation, all participants underwent dynamic contrast enhanced MRI and arthroscopic synovial biopsy sampling of a knee joint at inclusion. An interim analysis of the first 13 individuals has been performed; these data are shown in this abstract. Results were compared with knee MRI data and synovial biopsy data of 6 and 10 healthy controls, respectively. Results MRI findings evaluated by measurement of maximal enhancement, rate of enhancement, synovial volume and enhancement shape curve distribution were similar in the autoantibody positive individuals compared to the healthy controls. Consistent with these findings, all but one autoantibody positive individuals showed very low scores for T cells, B cells, intimal macrophages, sublining macrophages, fibroblast-like synoviocytes, plasma cells, E-selectin, ICAM-1, VCAM-1, and von WiIllebrand factor, all in the same range as those in normal controls. The patient with higher scores showed patellofemoral joint space narrowing on conventional x-ray consistent with osteoarthritis. During follow-up of a median of 37 (range 25–45) months, four individuals developed clinical signs and symptoms of arthritis. In these patients the baseline synovium was completely comparable with the synovium of healthy controls and of the individuals who did not develop arthritis. Data will be presented on the larger cohort. Conclusions Subclinical inflammation of the synovium does not coincide with the appearance of serum autoantibodies during the preclinical arthritis s
doi_str_mv 10.1136/ard.2010.149096.12
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777869541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008526881</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1912-bb1aebba172bd259880fa6fecba0ed365f3256de83c36f48e14f950cd05ccd363</originalsourceid><addsrcrecordid>eNqNkE1LwzAYx4MoOKdfwFPBc2de2jT1IjLdFMcUmTt4CUma0My-mbTDfXs7K3r19PDn__LAD4BzBCcIEXopXDbBcK-iFKZ0gvABGKGIshBDCg_BCEJIwiilyTE48X7TS8gQG4HHl1x3pWhrmwXCtbmzrfVXga22dbHVpa7aoDZBm-vA76p6a7uy975147QqbGWVKIImF15fn4IjIwqvz37uGLzO7lbT-3DxNH-Y3ixCiVKEQymR0FIKlGCZ4ThlDBpBjVZSQJ0RGhuCY5ppRhShJmIaRSaNocpgrFTvkzG4GHYbV3902rd8U3eu6l9ylCQJo2kcoT6Fh5RytfdOG944Wwq34wjyPTTeQ-N7aHyAxhHuS-FQsr7Vn78N4d45TUgS8-V6yue3M_L8tlzx9V9elpv_7H8B-bN-Bg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777869541</pqid></control><display><type>article</type><title>Rheumatoid arthritis: involvement of the synovium in the preclinical phase?</title><source>BMJ Journals - NESLi2</source><creator>de Hair, M J ; van de Sande, M G ; Bos, W ; van der Leij, C ; Smith, M D ; Maas, M ; van Schaardenburg, D ; Dijkmans, B A ; Gerlag, D M ; Tak, P P</creator><creatorcontrib>de Hair, M J ; van de Sande, M G ; Bos, W ; van der Leij, C ; Smith, M D ; Maas, M ; van Schaardenburg, D ; Dijkmans, B A ; Gerlag, D M ; Tak, P P</creatorcontrib><description>Background and objectives The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease, is poorly understood. Increased serum levels of acute phase reactants and autoantibodies (IgM rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA)) may be detected several years before the development of clinical signs and symptoms. Moreover, animal models of RA as well as examination of clinically uninvolved joints from established RA patients have suggested that clinically manifest arthritis may be preceded by an asymptomatic phase characterised by synovial inflammation. However, it is unknown whether the disease process starts in the synovium or at other sites in the body. Materials and methods Fifty five individuals without any evidence of arthritis upon physical examination who were positive for IgM-RF and/or ACPA were included in the study and prospectively followed to assess arthritis development. To evaluate synovial inflammation, all participants underwent dynamic contrast enhanced MRI and arthroscopic synovial biopsy sampling of a knee joint at inclusion. An interim analysis of the first 13 individuals has been performed; these data are shown in this abstract. Results were compared with knee MRI data and synovial biopsy data of 6 and 10 healthy controls, respectively. Results MRI findings evaluated by measurement of maximal enhancement, rate of enhancement, synovial volume and enhancement shape curve distribution were similar in the autoantibody positive individuals compared to the healthy controls. Consistent with these findings, all but one autoantibody positive individuals showed very low scores for T cells, B cells, intimal macrophages, sublining macrophages, fibroblast-like synoviocytes, plasma cells, E-selectin, ICAM-1, VCAM-1, and von WiIllebrand factor, all in the same range as those in normal controls. The patient with higher scores showed patellofemoral joint space narrowing on conventional x-ray consistent with osteoarthritis. During follow-up of a median of 37 (range 25–45) months, four individuals developed clinical signs and symptoms of arthritis. In these patients the baseline synovium was completely comparable with the synovium of healthy controls and of the individuals who did not develop arthritis. Data will be presented on the larger cohort. Conclusions Subclinical inflammation of the synovium does not coincide with the appearance of serum autoantibodies during the preclinical arthritis stage. Thus, systemic autoimmunity precedes the development of synovitis, suggesting that a ‘second hit’ is involved. Moreover, even if there are no signs of synovial inflammation, autoantibody positive individuals may suffer from arthralgia.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2010.149096.12</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 2), p.A5-A6</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/70/Suppl_2/A5.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/70/Suppl_2/A5.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,315,781,785,3197,23576,27929,27930,77605,77636</link.rule.ids></links><search><creatorcontrib>de Hair, M J</creatorcontrib><creatorcontrib>van de Sande, M G</creatorcontrib><creatorcontrib>Bos, W</creatorcontrib><creatorcontrib>van der Leij, C</creatorcontrib><creatorcontrib>Smith, M D</creatorcontrib><creatorcontrib>Maas, M</creatorcontrib><creatorcontrib>van Schaardenburg, D</creatorcontrib><creatorcontrib>Dijkmans, B A</creatorcontrib><creatorcontrib>Gerlag, D M</creatorcontrib><creatorcontrib>Tak, P P</creatorcontrib><title>Rheumatoid arthritis: involvement of the synovium in the preclinical phase?</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background and objectives The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease, is poorly understood. Increased serum levels of acute phase reactants and autoantibodies (IgM rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA)) may be detected several years before the development of clinical signs and symptoms. Moreover, animal models of RA as well as examination of clinically uninvolved joints from established RA patients have suggested that clinically manifest arthritis may be preceded by an asymptomatic phase characterised by synovial inflammation. However, it is unknown whether the disease process starts in the synovium or at other sites in the body. Materials and methods Fifty five individuals without any evidence of arthritis upon physical examination who were positive for IgM-RF and/or ACPA were included in the study and prospectively followed to assess arthritis development. To evaluate synovial inflammation, all participants underwent dynamic contrast enhanced MRI and arthroscopic synovial biopsy sampling of a knee joint at inclusion. An interim analysis of the first 13 individuals has been performed; these data are shown in this abstract. Results were compared with knee MRI data and synovial biopsy data of 6 and 10 healthy controls, respectively. Results MRI findings evaluated by measurement of maximal enhancement, rate of enhancement, synovial volume and enhancement shape curve distribution were similar in the autoantibody positive individuals compared to the healthy controls. Consistent with these findings, all but one autoantibody positive individuals showed very low scores for T cells, B cells, intimal macrophages, sublining macrophages, fibroblast-like synoviocytes, plasma cells, E-selectin, ICAM-1, VCAM-1, and von WiIllebrand factor, all in the same range as those in normal controls. The patient with higher scores showed patellofemoral joint space narrowing on conventional x-ray consistent with osteoarthritis. During follow-up of a median of 37 (range 25–45) months, four individuals developed clinical signs and symptoms of arthritis. In these patients the baseline synovium was completely comparable with the synovium of healthy controls and of the individuals who did not develop arthritis. Data will be presented on the larger cohort. Conclusions Subclinical inflammation of the synovium does not coincide with the appearance of serum autoantibodies during the preclinical arthritis stage. Thus, systemic autoimmunity precedes the development of synovitis, suggesting that a ‘second hit’ is involved. Moreover, even if there are no signs of synovial inflammation, autoantibody positive individuals may suffer from arthralgia.</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkE1LwzAYx4MoOKdfwFPBc2de2jT1IjLdFMcUmTt4CUma0My-mbTDfXs7K3r19PDn__LAD4BzBCcIEXopXDbBcK-iFKZ0gvABGKGIshBDCg_BCEJIwiilyTE48X7TS8gQG4HHl1x3pWhrmwXCtbmzrfVXga22dbHVpa7aoDZBm-vA76p6a7uy975147QqbGWVKIImF15fn4IjIwqvz37uGLzO7lbT-3DxNH-Y3ixCiVKEQymR0FIKlGCZ4ThlDBpBjVZSQJ0RGhuCY5ppRhShJmIaRSaNocpgrFTvkzG4GHYbV3902rd8U3eu6l9ylCQJo2kcoT6Fh5RytfdOG944Wwq34wjyPTTeQ-N7aHyAxhHuS-FQsr7Vn78N4d45TUgS8-V6yue3M_L8tlzx9V9elpv_7H8B-bN-Bg</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>de Hair, M J</creator><creator>van de Sande, M G</creator><creator>Bos, W</creator><creator>van der Leij, C</creator><creator>Smith, M D</creator><creator>Maas, M</creator><creator>van Schaardenburg, D</creator><creator>Dijkmans, B A</creator><creator>Gerlag, D M</creator><creator>Tak, P P</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201103</creationdate><title>Rheumatoid arthritis: involvement of the synovium in the preclinical phase?</title><author>de Hair, M J ; van de Sande, M G ; Bos, W ; van der Leij, C ; Smith, M D ; Maas, M ; van Schaardenburg, D ; Dijkmans, B A ; Gerlag, D M ; Tak, P P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1912-bb1aebba172bd259880fa6fecba0ed365f3256de83c36f48e14f950cd05ccd363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Hair, M J</creatorcontrib><creatorcontrib>van de Sande, M G</creatorcontrib><creatorcontrib>Bos, W</creatorcontrib><creatorcontrib>van der Leij, C</creatorcontrib><creatorcontrib>Smith, M D</creatorcontrib><creatorcontrib>Maas, M</creatorcontrib><creatorcontrib>van Schaardenburg, D</creatorcontrib><creatorcontrib>Dijkmans, B A</creatorcontrib><creatorcontrib>Gerlag, D M</creatorcontrib><creatorcontrib>Tak, P P</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Hair, M J</au><au>van de Sande, M G</au><au>Bos, W</au><au>van der Leij, C</au><au>Smith, M D</au><au>Maas, M</au><au>van Schaardenburg, D</au><au>Dijkmans, B A</au><au>Gerlag, D M</au><au>Tak, P P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rheumatoid arthritis: involvement of the synovium in the preclinical phase?</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2011-03</date><risdate>2011</risdate><volume>70</volume><issue>Suppl 2</issue><spage>A5</spage><epage>A6</epage><pages>A5-A6</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background and objectives The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease, is poorly understood. Increased serum levels of acute phase reactants and autoantibodies (IgM rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA)) may be detected several years before the development of clinical signs and symptoms. Moreover, animal models of RA as well as examination of clinically uninvolved joints from established RA patients have suggested that clinically manifest arthritis may be preceded by an asymptomatic phase characterised by synovial inflammation. However, it is unknown whether the disease process starts in the synovium or at other sites in the body. Materials and methods Fifty five individuals without any evidence of arthritis upon physical examination who were positive for IgM-RF and/or ACPA were included in the study and prospectively followed to assess arthritis development. To evaluate synovial inflammation, all participants underwent dynamic contrast enhanced MRI and arthroscopic synovial biopsy sampling of a knee joint at inclusion. An interim analysis of the first 13 individuals has been performed; these data are shown in this abstract. Results were compared with knee MRI data and synovial biopsy data of 6 and 10 healthy controls, respectively. Results MRI findings evaluated by measurement of maximal enhancement, rate of enhancement, synovial volume and enhancement shape curve distribution were similar in the autoantibody positive individuals compared to the healthy controls. Consistent with these findings, all but one autoantibody positive individuals showed very low scores for T cells, B cells, intimal macrophages, sublining macrophages, fibroblast-like synoviocytes, plasma cells, E-selectin, ICAM-1, VCAM-1, and von WiIllebrand factor, all in the same range as those in normal controls. The patient with higher scores showed patellofemoral joint space narrowing on conventional x-ray consistent with osteoarthritis. During follow-up of a median of 37 (range 25–45) months, four individuals developed clinical signs and symptoms of arthritis. In these patients the baseline synovium was completely comparable with the synovium of healthy controls and of the individuals who did not develop arthritis. Data will be presented on the larger cohort. Conclusions Subclinical inflammation of the synovium does not coincide with the appearance of serum autoantibodies during the preclinical arthritis stage. Thus, systemic autoimmunity precedes the development of synovitis, suggesting that a ‘second hit’ is involved. Moreover, even if there are no signs of synovial inflammation, autoantibody positive individuals may suffer from arthralgia.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/ard.2010.149096.12</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 2), p.A5-A6
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1777869541
source BMJ Journals - NESLi2
title Rheumatoid arthritis: involvement of the synovium in the preclinical phase?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T05%3A29%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rheumatoid%20arthritis:%20involvement%20of%20the%20synovium%20in%20the%20preclinical%20phase?&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=de%20Hair,%20M%20J&rft.date=2011-03&rft.volume=70&rft.issue=Suppl%202&rft.spage=A5&rft.epage=A6&rft.pages=A5-A6&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2010.149096.12&rft_dat=%3Cproquest_cross%3E4008526881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777869541&rft_id=info:pmid/&rfr_iscdi=true